Professional profile
About Priya
Asia-Pacific Life Sciences and Clinical Research Counsel in Singapore
Priya Menon advises life sciences companies on Asia-Pacific clinical development, CRO contracting, health data protection and cross-border regulatory strategy from Singapore.
Ms. Menon is admitted in Singapore. She holds a law degree from a Singapore university and has fourteen years of professional experience, working in English, Mandarin and Tamil with bar credentials on file.
Clinical trials across Asia now run through multiple regulatory regimes. Sponsors must reconcile enrollment commitments, milestone definitions and liquidated damages across jurisdictions where site activation means different things.
Clinical Trial Contracting and CRO Oversight
Best efforts to enroll is how sponsors fund a dispute with no winner. She drafts milestone definitions, dependency schedules and evidence packs for withholding fees.
Weekly funnel reports are made contractual deliverables; missing reports are themselves a breach, not a surprise at the quarterly business review. Change orders and dependency notices are documented in writing.
When sites under-enroll, the evidence pack includes protocol versions and amendment logs, site lists with activation dates, screening and enrollment funnel exports, and change orders with dependency notices.
Health Data and Cross-Border Privacy
RWE decks assume data already exists, so research is free. Asian privacy regimes treat secondary use as a design problem, not a footnote.
She runs the purpose binding, legal basis and consent map, minimisation, transfer path and vendor DPIA sequence before model training starts on a laptop export. Where analytics compute matters: mainland China versus global warehouses.
Hospital contracts are reviewed for re-use and sub-processing rights to SaaS stacks. Anonymisation versus de-identification is tested against residual re-identification risk in small cohorts.
How to Engage
Provide program structure, trial sites, data flows and any contractual or privacy notice already received. Scope is confirmed in writing through this profile's inquiry channel.
Capability
